ASTRAZENECA PLC

Remarks in Senate

Taxation: proposed merger of Pfizer Inc., and AstraZeneca PLC relative to treatment of existing inversions by corporations to avoid the U.S. corporate tax by reincorporating in a foreign country, S2932–S2935 [13MY]